UCI statement on Blaza Klemencic
The Union Cycliste Internationale (UCI) announces that the UCI Anti-Doping Tribunal has rendered its decision in the case involving Blaza Klemencic.
The matter resulted from the reanalysis of a sample provided by Blaza Klemencic in the scope of an out-of-competition control on 27 March 2012, which revealed the presence of Recombinant Erythropoietin (*).
The Anti-Doping Tribunal found the rider guilty of an anti-doping rule violation and imposed a 2-year period of ineligibility on the rider.
Moreover, the results obtained by the rider from 27 March 2012 to 31 December 2012 are disqualified, whilst all other results shall stand.
In accordance with the Procedural Rules of the Anti-Doping Tribunal, the decision will shortly be published on the UCI website.
(*) As per the World Anti-Doping Code and the UCI Anti-Doping Rules, the UCI has established a Storage and Reanalysis Strategy. The strategy, implemented by the Cycling Anti-Doping Foundation (CADF), provides that samples from the leaders of the Grand Tours, UCI World Championships and general rankings of all cycling disciplines will be stored for potential retesting. Other samples, based on risk assessment carried out by the CADF, laboratory recommendations, Athlete Biological Passport data, new detection methods and scientific developments, will also be retained for retesting. The standard time of storage and further reanalysis under this strategy is up to 10 years.